Cargando…

A Mathematical Model of the Phosphoinositide Pathway

Phosphoinositides are signalling lipids that constitute a complex network regulating many cellular processes. We propose a computational model that accounts for all species of phosphoinositides in the plasma membrane of mammalian cells. The model replicates the steady-state of the pathway and most k...

Descripción completa

Detalles Bibliográficos
Autores principales: Olivença, Daniel V., Uliyakina, Inna, Fonseca, Luis L., Amaral, Margarida D., Voit, Eberhard O., Pinto, Francisco R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834545/
https://www.ncbi.nlm.nih.gov/pubmed/29500467
http://dx.doi.org/10.1038/s41598-018-22226-8
_version_ 1783303667090194432
author Olivença, Daniel V.
Uliyakina, Inna
Fonseca, Luis L.
Amaral, Margarida D.
Voit, Eberhard O.
Pinto, Francisco R.
author_facet Olivença, Daniel V.
Uliyakina, Inna
Fonseca, Luis L.
Amaral, Margarida D.
Voit, Eberhard O.
Pinto, Francisco R.
author_sort Olivença, Daniel V.
collection PubMed
description Phosphoinositides are signalling lipids that constitute a complex network regulating many cellular processes. We propose a computational model that accounts for all species of phosphoinositides in the plasma membrane of mammalian cells. The model replicates the steady-state of the pathway and most known dynamic phenomena. Sensitivity analysis demonstrates model robustness to alterations in the parameters. Model analysis suggest that the greatest contributor to phosphatidylinositol 4,5-biphosphate (PI(4,5)P(2)) production is a flux representing the direct transformation of PI into PI(4,5)P(2), also responsible for the maintenance of this pool when phosphatidylinositol 4-phosphate (PI(4)P) is decreased. PI(5)P is also shown to be a significant source for PI(4,5)P(2) production. The model was validated with siRNA screens that knocked down the expression of enzymes in the pathway. The screen monitored the activity of the epithelium sodium channel (ENaC), which is activated by PI(4,5)P(2). While the model may deepen our understanding of other physiological processes involving phosphoinositides, we highlight therapeutic effects of ENaC modulation in Cystic Fibrosis (CF). The model suggests control strategies where the activities of the enzyme phosphoinositide 4-phosphate 5-kinase I (PIP5KI) or the PI4K + PIP5KI + DVL protein complex are decreased and cause an efficacious reduction in PI(4,5)P(2) levels while avoiding undesirable alterations in other phosphoinositide pools.
format Online
Article
Text
id pubmed-5834545
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-58345452018-03-05 A Mathematical Model of the Phosphoinositide Pathway Olivença, Daniel V. Uliyakina, Inna Fonseca, Luis L. Amaral, Margarida D. Voit, Eberhard O. Pinto, Francisco R. Sci Rep Article Phosphoinositides are signalling lipids that constitute a complex network regulating many cellular processes. We propose a computational model that accounts for all species of phosphoinositides in the plasma membrane of mammalian cells. The model replicates the steady-state of the pathway and most known dynamic phenomena. Sensitivity analysis demonstrates model robustness to alterations in the parameters. Model analysis suggest that the greatest contributor to phosphatidylinositol 4,5-biphosphate (PI(4,5)P(2)) production is a flux representing the direct transformation of PI into PI(4,5)P(2), also responsible for the maintenance of this pool when phosphatidylinositol 4-phosphate (PI(4)P) is decreased. PI(5)P is also shown to be a significant source for PI(4,5)P(2) production. The model was validated with siRNA screens that knocked down the expression of enzymes in the pathway. The screen monitored the activity of the epithelium sodium channel (ENaC), which is activated by PI(4,5)P(2). While the model may deepen our understanding of other physiological processes involving phosphoinositides, we highlight therapeutic effects of ENaC modulation in Cystic Fibrosis (CF). The model suggests control strategies where the activities of the enzyme phosphoinositide 4-phosphate 5-kinase I (PIP5KI) or the PI4K + PIP5KI + DVL protein complex are decreased and cause an efficacious reduction in PI(4,5)P(2) levels while avoiding undesirable alterations in other phosphoinositide pools. Nature Publishing Group UK 2018-03-02 /pmc/articles/PMC5834545/ /pubmed/29500467 http://dx.doi.org/10.1038/s41598-018-22226-8 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Olivença, Daniel V.
Uliyakina, Inna
Fonseca, Luis L.
Amaral, Margarida D.
Voit, Eberhard O.
Pinto, Francisco R.
A Mathematical Model of the Phosphoinositide Pathway
title A Mathematical Model of the Phosphoinositide Pathway
title_full A Mathematical Model of the Phosphoinositide Pathway
title_fullStr A Mathematical Model of the Phosphoinositide Pathway
title_full_unstemmed A Mathematical Model of the Phosphoinositide Pathway
title_short A Mathematical Model of the Phosphoinositide Pathway
title_sort mathematical model of the phosphoinositide pathway
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834545/
https://www.ncbi.nlm.nih.gov/pubmed/29500467
http://dx.doi.org/10.1038/s41598-018-22226-8
work_keys_str_mv AT olivencadanielv amathematicalmodelofthephosphoinositidepathway
AT uliyakinainna amathematicalmodelofthephosphoinositidepathway
AT fonsecaluisl amathematicalmodelofthephosphoinositidepathway
AT amaralmargaridad amathematicalmodelofthephosphoinositidepathway
AT voiteberhardo amathematicalmodelofthephosphoinositidepathway
AT pintofranciscor amathematicalmodelofthephosphoinositidepathway
AT olivencadanielv mathematicalmodelofthephosphoinositidepathway
AT uliyakinainna mathematicalmodelofthephosphoinositidepathway
AT fonsecaluisl mathematicalmodelofthephosphoinositidepathway
AT amaralmargaridad mathematicalmodelofthephosphoinositidepathway
AT voiteberhardo mathematicalmodelofthephosphoinositidepathway
AT pintofranciscor mathematicalmodelofthephosphoinositidepathway